MRD at EOI. Prevalence of MRD ≥0.01% at EOI in the IDEAL cohort as compared with historical controls and stratified by starting BMI. In the IDEAL trial, 24 of 38 (63%) evaluable for MRD at EOI were OW/OB as compared with 35 of 80 (44%) in the historical control.